Studying the pathogenesis of non-small cell lung cancer, we observed that overactivation of the MAPK pathway and PI3K/AKT pathway is a cause of NSCLC formation (Figure 2), and abnormal activation of these pathways is also an important drug-resistance mechanism in NSCLC. The gene discussed is PIK3CA; the disease is non-small cell lung carcinoma.